Search - tctmd.com

Displaying 41 - 60 of 138

Sort: Relevancy | Date

Presentation Fellows 2015

Case 1

Presenter: Roxana Mehran, David J. Cohen, Robert W. Yeh

May 15, 2015

Presentation Fellows 2015

Antithrombin Pharmacology for the Interventionalist

Presenter: Manish A. Parikh, Roxana Mehran, David J. Cohen

May 15, 2015

News Daily News

TAVR可改善大多数高危患者的健康相关生活质量

L.A. McKeown

February 19, 2015

News Daily News

TAVR Mejora la Calidad de Vida asociada a la Salud en la Mayoría de Pacientes de Riesgo Extremo

L.A. McKeown

February 19, 2015

News Daily News

TAVR Improves Health-Related QoL in Majority of Extreme-Risk Patients

L.A. McKeown

February 19, 2015

Presentation TCT 2014

TCT 347: Assessment of Intravascular Ultrasound-Derived Minimal Lumen Area and Fractional Flow Reserve to Evaluate Functionally Significant Coronary Artery Disease: A Meta-analysis

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Jae-Sik Jang, MD

September 13, 2014

Presentation TCT 2014

TCT 252: Preprocedural Statin Administration Benefit According to Baseline Renal Function: A Meta-analysis of Randomized Controlled Trials

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Daniele Giacoppo, MD

September 13, 2014

Presentation TCT 2014

Meta-analysis: From PRISMA Standards to Utility in Guiding Practice

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Sripal Bangalore

September 13, 2014

Presentation TCT 2014

Definition, Reliability, and Interpretation of Surrogate Endpoints

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen

September 13, 2014

Presentation TCT 2014

Subgroup Analyses: Proceed (and Interpret) with Caution

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Eugene H. Blackstone

September 13, 2014

Presentation TCT 2014

Randomized vs Observational Studies: Strengths and Weaknesses

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen

September 13, 2014

Presentation TCT 2014

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke

September 13, 2014

Presentation TCT 2014

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds

September 13, 2014

Presentation TCT 2014

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia

September 13, 2014

News Daily News

Link Between PCI Volume and Outcomes Remains Intact

Todd Neale

September 13, 2014

News Daily News

El Nexo que existe entre Volumen PCI y Resultados Sigue Intacto

Todd Neale

September 13, 2014

News Daily News

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

August 20, 2014

News Daily News

SYNTAX al cabo de 5 Años: CABG es Más Rentable que la PCI

August 20, 2014

News Daily News

5年时SYNTAX：CABG比PCI更具成本效益优势

August 20, 2014

Presentation

Cost-Effectiveness of PCI with DES vs Bypass Surgery for Patients with 3-Vessel or Left Main CAD

Presenter: David J. Cohen

August 11, 2014

Advertisement

Case 1

Antithrombin Pharmacology for the Interventionalist

TAVR可改善大多数高危患者的健康相关生活质量

TAVR Mejora la Calidad de Vida asociada a la Salud en la Mayoría de Pacientes de Riesgo Extremo

TAVR Improves Health-Related QoL in Majority of Extreme-Risk Patients

TCT 347: Assessment of Intravascular Ultrasound-Derived Minimal Lumen Area and Fractional Flow Reserve to Evaluate Functionally Significant Coronary Artery Disease: A Meta-analysis

TCT 252: Preprocedural Statin Administration Benefit According to Baseline Renal Function: A Meta-analysis of Randomized Controlled Trials

Meta-analysis: From PRISMA Standards to Utility in Guiding Practice

Definition, Reliability, and Interpretation of Surrogate Endpoints

Subgroup Analyses: Proceed (and Interpret) with Caution

Randomized vs Observational Studies: Strengths and Weaknesses

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Link Between PCI Volume and Outcomes Remains Intact

El Nexo que existe entre Volumen PCI y Resultados Sigue Intacto

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

SYNTAX al cabo de 5 Años: CABG es Más Rentable que la PCI

5年时SYNTAX：CABG比PCI更具成本效益优势

Cost-Effectiveness of PCI with DES vs Bypass Surgery for Patients with 3-Vessel or Left Main CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content